Literature DB >> 7536039

Use of synthetic peptides and copolymers to study the substrate specificity and inhibition of the protein tyrosine kinase pp60c-src.

R J Budde1, N U Obeyesekere, S Ke, J S McMurray.   

Abstract

The ability of synthetic peptides and polypeptides to act as substrates and/or inhibitors of pp60c-src was examined. The random copolymer, poly(K4Y) had a threefold lower specificity than poly(E4Y). Peptides containing lysine vs. glutamate were also found to have a lower substrate specificity (Vmax:Km ratio). In order to assess the substrate specificity of acidic peptides, an assay protocol using DEAE-membranes was developed. Peptides containing a (YXE)5YXD motif (X = G, A, V, P, or norvaline) were tested as inhibitors and substrates of pp60c-src. The glycine-containing peptide was the best substrate having a specificity 16,000-fold higher than 5Val-angiotensin II, the most commonly used peptide substrate. Most of the peptides, except for the proline containing peptide, had Ki values of 20-100 microM. In a series of (XGE)5XGD peptides, where X = Y or F, tyrosine at position 10 was found to be the preferred site for accepting a phosphate. Analogs in which the glycine was replaced with alanine indicated that loss of flexibility around position 10 was detrimental to substrate specificity. Results suggest that conformational requirements of the peptides tested was important and substrate specificity was a more sensitive parameter than binding as measured by Ki values.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7536039     DOI: 10.1016/0167-4838(94)00232-6

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  3 in total

1.  Synthesis and structure-activity relationships of linear and conformationally constrained peptide analogues of CIYKYY as Src tyrosine kinase inhibitors.

Authors:  Anil Kumar; Guofeng Ye; Yuehao Wang; Xiaofeng Lin; Gongqin Sun; Keykavous Parang
Journal:  J Med Chem       Date:  2006-06-01       Impact factor: 7.446

2.  Cyclic peptides containing tryptophan and arginine as Src kinase inhibitors.

Authors:  Amir Nasrolahi Shirazi; Rakesh Kumar Tiwari; Alex Brown; Dindyal Mandal; Gongqin Sun; Keykavous Parang
Journal:  Bioorg Med Chem Lett       Date:  2013-04-06       Impact factor: 2.823

3.  Small flexible structure for targeted delivery of therapeutic and imaging moieties in precision medicine.

Authors:  Shaofan Hu; Wei Wang; Yanling Zhang; Bingjie Li; Xiuchun Qiu; Chaoxia Zou; Henry Ran; Fujun Zhang; Shi Ke
Journal:  Oncotarget       Date:  2016-05-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.